Objective: To characterize the bacteriocin-like inhibitory-substances(BLIS) activity of Streptococcus macedonicus MBF10-2 [named BLIS(MBF10-2)], a bacteriocinogenic strain isolated from an Indonesian tofu byproduct.Me...Objective: To characterize the bacteriocin-like inhibitory-substances(BLIS) activity of Streptococcus macedonicus MBF10-2 [named BLIS(MBF10-2)], a bacteriocinogenic strain isolated from an Indonesian tofu byproduct.Methods: BLIS(MBF10-2) was obtained by culturing the bacterium, and standard deferred antagonism assays were used to demonstrate its activity. The antibacterial testing of fractions collected by filtration using 3–30 kDa cut-off membrane sizes were carried out by performing well diffusion method.Results: The growth of Micrococcus luteus, Streptococcus pyogenes, Lactococcus lactis,Leuconostoc mesenteroides and Weissella confusa were inhibited by BLIS(MBF10-2).Interestingly, BLIS-containing fractions obtained from sequential application on ultrafiltration membranes indicated that this bacterium Streptococcus macedonicus MBF10-2 could produces at least two antimicrobial peptides activities, one of which is likely to be a lantibiotic peptide. Potential synergistic activity against certain Gram-positive(but not Gram-negative) species when partnered with antibiotics(ampicillin, tetracycline or kanamycin) were observed.Conclusion: Combination of some BLIS(MBF10-2) active fractions with antibiotics(ampicillin, tetracycline or kanamycin) could demonstrate synergistic activities against certain Gram-positive species.展开更多
基金supported partly by TWAS Research Grant for Basic Science(10-088 RG/BIO/AS_G-UNESCO FR:3240246003 and 14-094 RG/BIO/AS_G-UNESCO FR:324028606)to A.M.a New Zealand Dental Association Research Foundation grant to N.H
文摘Objective: To characterize the bacteriocin-like inhibitory-substances(BLIS) activity of Streptococcus macedonicus MBF10-2 [named BLIS(MBF10-2)], a bacteriocinogenic strain isolated from an Indonesian tofu byproduct.Methods: BLIS(MBF10-2) was obtained by culturing the bacterium, and standard deferred antagonism assays were used to demonstrate its activity. The antibacterial testing of fractions collected by filtration using 3–30 kDa cut-off membrane sizes were carried out by performing well diffusion method.Results: The growth of Micrococcus luteus, Streptococcus pyogenes, Lactococcus lactis,Leuconostoc mesenteroides and Weissella confusa were inhibited by BLIS(MBF10-2).Interestingly, BLIS-containing fractions obtained from sequential application on ultrafiltration membranes indicated that this bacterium Streptococcus macedonicus MBF10-2 could produces at least two antimicrobial peptides activities, one of which is likely to be a lantibiotic peptide. Potential synergistic activity against certain Gram-positive(but not Gram-negative) species when partnered with antibiotics(ampicillin, tetracycline or kanamycin) were observed.Conclusion: Combination of some BLIS(MBF10-2) active fractions with antibiotics(ampicillin, tetracycline or kanamycin) could demonstrate synergistic activities against certain Gram-positive species.
